-
2X HyperFusion High-Fidelity Master Mix Workflow
2026-09-14
Build accurate cloning, construct-verification, and CRISPR assay workflows with a ready-to-use proofreading mix designed for robust amplification. This guide connects high-fidelity PCR decisions to the CD47-targeting nanomedicine study while clearly separating validated product capabilities from practical workflow recommendations.
-
Cell-Surface LAMP1 as a Senescence Marker
2026-09-14
This 2025 Aging Cell study identifies cell-surface LAMP1 as a membrane-accessible marker associated with senescence across human and mouse models, including aging and bleomycin-induced lung fibrosis. Its combination of marker validation, lung-tissue transcriptomics, and a dual antibody–drug conjugate experiment provides a framework for detecting and selectively eliminating senescent cells, while also highlighting the need for further tissue and in vivo validation.
-
Proteostasis as a Translational Oncology Lever
2026-09-13
Bortezomib (PS-341) is more than a cytotoxic benchmark: it is a reversible 20S proteasome inhibitor that can help researchers connect protein turnover, apoptosis, and metabolic state. This article translates recent mitochondrial proteostasis findings into a disciplined framework for oncology experiments without overstating an unproven mechanistic link.
-
Phalloidin (B7678): Practical F-Actin Workflow
2026-09-12
Phalloidin (B7678) is a high-affinity F-actin-binding reagent for preserving and visualizing filament organization in fixed or permeabilized samples. It is suited to endpoint cytoskeleton analysis, but not to live-cell imaging or experiments that require reversible actin interactions.
-
Torin2: Precision mTOR Inhibitor Workflows
2026-09-12
Torin2 combines subnanomolar mTOR potency with a practical workflow for pathway inhibition, viability profiling, and apoptosis assay design. This guide shows how to use it in cancer research, including medullary thyroid carcinoma models, while avoiding solubility, timing, and interpretation errors.
-
Chlorambucil: From DNA Damage to Better Translation
2026-09-11
Chlorambucil is more than a legacy chemotherapy reference compound: it is a practical model for linking DNA crosslinking, assay interpretation, and translational decision-making. This article outlines how researchers can use its mechanistic clarity and model-dependent cytotoxicity to build more informative oncology workflows.
-
Coelenterazine Workflows for ROS Reporter Assays
2026-09-11
Coelenterazine unites coelenterate luciferase reporting with chemiluminescent detection of superoxide anion and peroxynitrite. This guide shows how to separate reporter activity from oxidative chemistry across AVP assays, BRET, high-throughput screening, and cancer-associated reactive oxygen species imaging.
-
Cy5-UTP Maps RNA Condensates to Translational Insight
2026-09-10
STAU2 condensates coordinate mRNA transport and local translation in developing neurons. This thought-leadership guide shows how Cy5-UTP and Cyanine 5-uridine triphosphate can turn that mechanism into an experimentally testable workflow for FISH, RNA probe synthesis, and translational research.
-
Ginsenoside Rg1 for Reliable Cell Assays
2026-09-10
Learn how Ginsenoside Rg1, SKU N1613, can support reproducible viability, cytotoxicity, apoptosis, and neuroprotection research. This scenario-based guide covers solvent controls, protocol design, interpretation, and product-selection criteria grounded in product data and recent in vivo evidence.
-
Anisomycin, JNK Signaling, and Translational Memory Biology
2026-09-09
Anisomycin is more than a apoptosis reagent: it is a controlled stress-signaling probe that can help translational researchers connect JNK pathway activation with cell fate decisions while testing, cautiously and mechanistically, how proteolytic synaptic remodeling may intersect with broader stress biology.
-
ω-Agatoxin IVA in Cav2.1-Dependent Epileptogenesis
2026-09-09
The reference study shows that selective P/Q-type calcium channel blockade with ω-agatoxin IVA suppresses seizure development in a rat chemical-kindling model while altering BDNF and cleaved caspase-3 expression. Its combination of behavioral, electroencephalographic, and immunohistochemical measurements provides a mechanistic framework for studying Cav2.1 channels, neuronal survival, and epileptogenesis.
-
YC-1 in Hypoxia, Cancer, and Mechanistic Assays
2026-09-08
YC-1 combines soluble guanylyl cyclase activation with research use in HIF-1α and hypoxia assays, making it useful for separating oxygen-sensitive signaling from general cytotoxicity. This guide translates those properties into practical cancer workflows and a carefully bounded, hypothesis-generating extension of CGRP/SP-Piezo2 neuroinflammation research.
-
One-step TUNEL Cy3 Apoptosis Detection Kit
2026-09-07
The One-step TUNEL Cy3 Apoptosis Detection Kit connects DNA fragmentation measurement with modern targeted-cancer research. This article explains how to interpret TUNEL signals in AKT1-focused colorectal cancer studies, select appropriate controls, and distinguish apoptotic phenotype from broader cytotoxicity.
-
Toremifene in Prostate Cancer Research
2026-09-07
Use Toremifene as a controllable estrogen receptor perturbation alongside viability, calcium-flux, and migration assays. This workflow connects hormone-responsive cancer research with the TSPAN18–STIM1 metastasis model while clearly separating established findings from testable hypotheses.
-
FITC-Concanavalin A (ConA) Conjugate Guide
2026-09-05
FITC-Concanavalin A (ConA) Conjugate is a fluorescent lectin conjugate for visualizing cell-associated α-D-glucose and α-D-mannose moieties in microscopy and flow cytometry workflows. It should be used for carbohydrate-focused assays, not non-carbohydrate targets or experiments outside the stated storage and stability conditions.